There is evidence that MRP5 transporter is over-expressed in the biological barriers of the brain, which could support the idea that ALL patients frequently relapse in the central nervous system (Warren et al., 2009); therefore, some genotypic modifications in the gene ABCC5 would enhance the severity of ALL. The gene discussed is ABCC5; the disease is acute lymphoblastic leukemia.